Aktiv auf dem Markt für Immuntherapeutika: das Pharmaunternehmen Stallergenes entwickelt Produkte zur Behandlung von Atemwegsallergien und ist Marktführer und Spezialist auf dem Gebiet der sublingualen Hyposensibilisierung.
http://www.stallergenes.de/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Sunday
LOAD TIME
0.5 seconds
PAGES IN
THIS WEBSITE
0
SSL
EXTERNAL LINKS
30
SITE IP
91.207.18.9
LOAD TIME
0.5 sec
SCORE
6.2
Labor, spezialisiert auf die Behandlung von Allergien – Stallergenes | stallergenes.de Reviews
https://stallergenes.de
Aktiv auf dem Markt für Immuntherapeutika: das Pharmaunternehmen Stallergenes entwickelt Produkte zur Behandlung von Atemwegsallergien und ist Marktführer und Spezialist auf dem Gebiet der sublingualen Hyposensibilisierung.
Kunden und Partner | plus3trainings
https://www.plus3trainings.eu/kunden-und-partner
Training Change Management Support @ Google Apps Doodle Insightly Podio more. Unsere Services bieten wir auch kleinen bis mittelständischen Unternehmen an. Pluspackone: CloudOffice und Beratung. ANNO 1838 e.V. Einrichtung Beratung Training Support. Partner für Google Apps for Work Schulungen in Hamburg Frankfurt Berlin München Düsseldorf Stuttgart. Raum 16, Hamburg: Weiterbildungen und Workshops. Kollaborativem Arbeiten und Customer Realtionship Management (CRM). Google Apps for Work in Videos erklärt.
Stallergenes-Studien
https://www.internet-studie.de/stallergenes-portal/index.htm
Studien und Projekte zur Dokumentation der Behandlung von Allergien. V 30 (05.09.2013). Nach Anklicken eines Buttons werden Sie auf einen Server mit einem hohen Sicherheitsstandard weitergeleitet. Ab sofort wird dann das SSL-Protokoll für sichere Verbindungen benutzt. Unsere Sicherheitsserver-Software verschlüsselt Ihre gesamten Daten. Diese Informationen können bei der Übertragung im Internet nicht von Unbefugten gelesen werden.
Unsere Kunden | Brickenkamp-PR
http://brickenkamp.de/unsere-kunden
Dr med. Arno Brickenkamp. Dr rer. nat. Jasmin Klose. Dr med. Arno Brickenkamp. Dr rer. nat. Jasmin Klose.
Investor Relations | stallergenesgreer.com
http://www.stallergenesgreer.com/investor-relations
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. Stallergenes Greer in Brief. Stallergenes Greer, a worldwide allergy company. Welcome to Stallergenes Greer. Two companies united in one fully integrated global biopharmaceutical company. Ready to make allergy history. January 27, 2017. Stallergenes Greer announces positive top line results of phase 3 study for pediatric house dust mite induced allergic rhinitis. Zip / Post Code.
Allergic diseases | stallergenesgreer.com
http://www.stallergenesgreer.com/allergic-diseases
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. Lifestyle changes have contributed to occurrences of allergies doubling the last decade. An allergy is an abnormal reaction of the immune system to substances which are usually harmless. Researchers think that people inherit a tendency to develop allergies from one or both parents. Its occurrence is said to have doubled during the past 20 years. It is estimated that 20 to 30...
Allergy diagnostic | stallergenesgreer.com
http://www.stallergenesgreer.com/allergy-diagnostic
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. Identifying the causal allergen can be an important step in taking control of your allergy. It is important to be properly diagnosed in order to receive adequate medical care. If left untreated, allergic rhinitis symptoms themselves can worsen, leading to a spiral of worsening co-existing conditions. Last accessed on May 11, 2016). Last accessed on May 18, 2016). 4 Heinzerling e...
Patient Services | stallergenesgreer.com
http://www.stallergenesgreer.com/patient-services
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. Putting patients first with end-to-end service solutions. Our commitment to help people with allergies live a normal life goes beyond treatment. In addition to our existing online AIT resources for allergy specialists, we have designed a range of integrated and customized service solutions that ensure a continuum of care for patients and support physicians. I-START promotes a co...
Partnerships | stallergenesgreer.com
http://www.stallergenesgreer.com/partnerships
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. In addition to capitalising on our core competencies, we are also active partners with best-in-class organisations around the world. Collaborating with partners helps us advance our research and develop products that can address the unmet needs of allergic patients. Current academic or early-stage collaborations include work with:. To evaluate PLGA-based micro-particulate formul...
Our commitment to AIT | stallergenesgreer.com
http://www.stallergenesgreer.com/our-commitment-ait
Skip to main content. Our Board of Directors. Our Global Leadership Team. Our commitment to AIT. Financial Calendar and Events. Changing the allergy treatment paradigm. Our commitment to AIT. Our commitment to AIT. Approximately 50% of allergic rhinitis patients. And nearly 30% of patients. On symptomatic treatment are not fully controlled. Patients are at the heart of progress in AIT as they have been for the past 150 years. Other products diagnostics tools and source materials. Spanning source material...
TOTAL LINKS TO THIS WEBSITE
30
Startseite
32;| FR. 32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Stallergenes der führende Spezialist in Total Allergy Management. Stallergenes ist ein führendes globales Pharmaunternehmen mit der Spezialisierung auf die Herstellung von Allergenextrakte für die Allergen-Immuntherapie (AIT). Die Schweizerische Stallergenes AG in Dietlikon (ZH) ist ein 100%-iges Tochterunternehmen von Stallergenes SA, Antony, Frankreich. In Zusammenarbeit mit Allergieexperten für eine optimale Behandlung der Patienten. Tropfen zur...
Homepage
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Stallergenes offers a comprehensive approach to allergic diseases by providing allergy specialists with a wide range of products, from diagnostics through to allergen immunotherapy treatments. With a strong focus on innovation, Stallergenes boasts unparalleled expertise in the field of allergy, and is making a major contribution to the development of allergen immunotherapy; offering allergy sufferers ever more innovative and tailored solutions.
Stallergenes, corporate website
32;| . 32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Announcement: The new Board of Ares Allergy appoints Fereydoun Firouz Chairman and CEO. Half-year sales: Strong revenue growth in H1 2015 (up 8.7%) exceeding targets. Stallergenes is pleased to see the mobile allergen exposure chamber at the 2015 EAACI congress, Barcelona. Follow us on :. STALLERGENES, A GLOBAL ALLERGY PLAYER. Stallergenes is a global pharmaceutical company with leading innovation, provider of allergy solutions all around the world.
STALLERGENES TÜRKİYE
Barbaros Mahallesi Tümer Sok No:17/2. Tel: 90 (216) 317 53 62. 90 (216) 470 00 91. Haritayı büyütmek için tıklayın. ORALAIR ERİŞKİN VE ÇOCUKLARDA ÇİM POLENİ ALERJİK RİNİT TEDAVİSİ İÇİN TÜRKİYE’DE PAZARLAMA RUHSATI ALIYOR. İstanbul (Türkiye), 20 Şubat 2014. Daha fazla bilgi edinin. Her yıl yaklaşık 500 000 hasta Stallergenes’in hastalığın ilerlemesini frenleyen tedavilerinden yararlanmaktadır.Bu gün, Stallergenes sublingual immünoterapide dünya lideridir ve ürünlerini geliştirmek için çalışmalarını ke...
Stallergenes, farmaceutická společnost specializující se na léčbu alergií
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. PYLOVÉ ALERGIE: CO KDYŽ SE ROZHODNETE, ŽE UŽ SE DALŠÍ JARO NEBUDETE TRÁPIT? Pro lidi, kteří trpí respirační alergií způsobenou pyly trav, není příchod. SILNÝ RŮST TRŽEB V 1. ČTVRTLETÍ (ZVÝŠENÍ o 7,5 %) PŘEKRAČUJE CÍLE. Celý článek naleznete v sekci Odborná veřejnost. 2,5 % RŮST ČISTÝCH TRŽEB EBITDA PŘEKONALA CÍLE ROKU 2014. Celý článek naleznete v sekci Odborná veřejnost. Společnost Stallergenes - Mezinárodní Farmaceutická společnost. 124; Respirační alergie.
Labor, spezialisiert auf die Behandlung von Allergien – Stallergenes
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Stallergenes führt seine internationale Expansion mit der Eröffnung der Filiale in Kanada fort. STALLERGENES führt seine INTERNATIONALe EXPANSION. Mit der eröffnung einer. Eine neue Generation von Methoden bei der Gewinnung von Gräserpollen, einem Rohmaterial zur Behandlung des Heuschnupfens mit der Tablette. Stallergenes, ein globales Allergieunternehmen. 124; Spezifische Immuntherapie. 124; Group sites. 124; Česká republika. 124; Middle East.
Stallergenes España
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Nace la primera web informativa en español sobre la inmunoterapia con alérgenos. Los niños con alergia a ácaros tienen el mayor riesgo de asma. BIENVENIDO A LA PÁGINA DE STALLERGENES. Stallergenes es una compañía farmacéutica internacional especializada en alergia que ofrece soluciones globales y eficientes a los pacientes, gracias a su liderazgo en innovación. Para obtener cualquier información sobre farmacovigilancia, haga click:. 124; La alergia. 124; Gro...
Stallergenes en France
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Alertes Pollens : application 2ème génération. Nouvelles fonctionnalités et contenu renforcé pour un service toujours. Stallergenes lance un nouveau film sur l'allergie aux acariens. En ce début d’automne, Stallergenes lance, sur internet, la diffusion. Stallergenes propose une approche globale des maladies allergiques en offrant aux médecins spécialistes de l’allergie une large gamme de produits, du diagnostic au traitement d'immunothérapie allergénique.
Stallergenes - Azienda farmaceutica specializzata nel trattamento delle allergie
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Leader nell’immunoterapia con allergeni contro gli acari della polvere: stato dell’arte ed ultime novità. Barcellona (Spagna), giugno 2015 Durante il simposio sponsorizzato. LA RIVISTA PER GLI SPECIALISTI IN ALLERGOLOGIA E’ ORA ONLINE! Scopri la versione online di Expressions, la rivista di Stallergenes. Stallergenes Italia, azienda farmaceutica specializzata nel trattamento delle allergie. I pollini sono tornati! Scopri la soluzione efficace nel tempo.
Farmaceutisch bedrijf gespecialiseerd in allergie - Stallergenes
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Professionals in de zorg. Stallergenes announces FDA approval of Oralair. ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue. Commercialization of Oralair in the US: possible cooperation with Greer Laboratories Inc. Antony, France, 8 March 2013 Stallergenes S.A. (Euronext Paris CAC. Wilt u weten welk beleid uw zorgverzekeraar hanteert ten aanzien van niet-geregistreerde allergeenproducten? Neemt u dan rechtstreeks contact met hen op.
Strona glówna
32;| . 14/08/2009 - 11:07:23 49.66 EUR 0.42 %. Stallergenes informuje o zawtwierdzeniu STG320, pierwszej tabletki do immunoterapii podjęzykowej stosowanej w leczeniu alergii na roztocze kurzu domowego. Pierwsze w Europie mobilne komory do badań klinicznych pacjentów z alergią. Firma Stallergenes oferuje kompleksowe podejście do leczenia chorób alergicznych dostarczając alergologom bogatą gamę produktów do diagnostyki i immunoterapii alergii. ALERGIA NA PYŁKI ROŚLIN. Ostatnie uaktualnienie : 28/07/2014.
